Hidradenitis Suppurativa Remission and Progression in a Community Setting

Are progression and remission rates of hidradenitis suppurativa (HS) the same in community as in hospital settings?This prospective cohort study including 107 participants found that the rate of progression to severe HS was 10.4 times lower and full remission rates were 3.8 times higher in the community compared with the hospital setting.These finding suggest that hospital-based data may not accurately reflect HS outcomes among patients in nonclinical settings.

Corresponding Author: Rune Kjærsgaard Andersen, MD, PhD, PHOENIX Research Center, Department of Dermatology and Allergy, Gentofte Hospital, Gentofte Hospitalsvej 20A, 2. Th., 2900 Hellerup, Denmark (rune.kjaersgaard.andersen@regionh.dk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.